Major Premium Buyout at Home Diagnostics, A Return To Old Prices (HDIX)
Home Diagnostics, Inc. (NASDAQ: HDIX) is this morning’s top pre-market gainer, on news of a buyout. The company has agreed to be acquired by Nipro Corporation for $11.50 per share in a $215 million buyout. This represents about a 90%…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The company makes blood glucose monitoring systems and disposable supplies for people with diabetes. If you wonder how the price was determined, this stock came public in late-2006 and briefly traded above $12.00 in 2006 and 2007.
At 8:27 AM EST we have seen some 1.12 million shares trade hands versus an average daily volume of only about 26,600 shares. The stock is up 89% at $11.47 and the prior 52-week trading range is $4.62 to $7.71.
JON C. OGG
Contact [email protected] for any questions or corrections.